Literature DB >> 25035648

Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Xin-Zu Chen1, Wei-Han Zhang1, Jian-Kun Hu1.   

Abstract

Based on Siewert classification, adenocarcinomas of the esophagogastric junction (AEGs) have different behaviors of perigastric-mediastinal nodal metastasis. Siewert type I AEGs have higher incidence of mediastinal nodal metastasis than those of type II or III, especially at middle-upper mediastinum. With regard to the necessity of mediastinal lymphadenectomy, theoretically, transthoracic esophagogastrectomy with complete mediastinal lymphadenectomy is suggested for Siewert type I AEGs, while transhiatal total gastrectomy with lower mediastinal and D2 perigastric lymphadenectomy is a standard surgery for type II-III AEGs. Nevertheless, the mediastinal nodal metastasis is an independent factor of poor prognosis for any type of AEG.

Entities:  

Keywords:  Adenocarcinomas of the esophagogastric junction (AEGs); lymph node; lymphadenectomy; metastasis; surgery

Year:  2014        PMID: 25035648      PMCID: PMC4076724          DOI: 10.3978/j.issn.1000-9604.2014.06.17

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  31 in total

1.  Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa; Yasushi Rino; Takashi Oshima; Toru Aoyama; Tsutomu Hayashi; Tsutomu Sato; Norio Yukawa; Yoichi Kameda; Takeshi Sasaki; Hidetaka Ono; Kazuhito Tsuchida; Haruhiko Cho; Chikara Kunisaki; Munetaka Masuda; Akira Tsuburaya
Journal:  Ann Surg Oncol       Date:  2013-08-14       Impact factor: 5.344

2.  Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.

Authors:  Hong-Dian Zhang; Peng Tang; Xiao-Feng Duan; Chuan-Gui Chen; Zhao Ma; Yong-Yin Gao; Hua Zhang; Zhen-Tao Yu
Journal:  J Surg Oncol       Date:  2013-09-09       Impact factor: 3.454

3.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Authors:  Yoshihiro Kakeji; Manabu Yamamoto; Shuhei Ito; Masahiko Sugiyama; Akinori Egashira; Hiroshi Saeki; Masaru Morita; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

4.  Survival after adjuvant chemoradiotherapy or surgery alone in resectable adenocarcinoma at the gastro-esophageal junction.

Authors:  S C Kofoed; A Muhic; L Baeksgaard; M Jendresen; J Gustafsen; J Holm; L Bardram; B Brandt; J Brenø; L B Svendsen
Journal:  Scand J Surg       Date:  2012       Impact factor: 2.360

5.  Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.

Authors:  Masaki Nakamura; Makoto Iwahashi; Mikihito Nakamori; Teiji Naka; Toshiyasu Ojima; Takeshi Iida; Masahiro Katsuda; Toshiaki Tsuji; Keiji Hayata; Shuuichi Mastumura; Hiroki Yamaue
Journal:  Am Surg       Date:  2012-05       Impact factor: 0.688

6.  [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].

Authors:  Shou-miao Li; Zi-yu Li; Xin Ji
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2013-04

7.  Lymph node micrometastases of adenocarcinoma located in gastroesophagal junction.

Authors:  Janusz Włodarczyk; James Mueller; Joanna Włodarczyk
Journal:  Pol J Pathol       Date:  2013-10       Impact factor: 1.072

8.  Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.

Authors:  S Mine; T Sano; N Hiki; K Yamada; S Nunobe; T Yamaguchi
Journal:  Br J Surg       Date:  2012-11-23       Impact factor: 6.939

9.  The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.

Authors:  Hironobu Goto; Masanori Tokunaga; Yuichiro Miki; Rie Makuuchi; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2014-03-22       Impact factor: 7.370

10.  Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.

Authors:  Hao Zhang; Wei Wang; Yao Cheng; Yongchun Song; Kun Zhu; Chengxue Dang
Journal:  World J Surg Oncol       Date:  2013-07-13       Impact factor: 2.754

View more
  8 in total

1.  The thinking to the huge disease burden of gastric cancer in China and the increasing tendency of esophagogastric junctional adenocarcinoma.

Authors:  Kun Yang; Jian-Kun Hu
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-13

2.  Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.

Authors:  Huihua Cao; Marie Ooi; Zhan Yu; Qing Wang; Zhong Li; Qicheng Lu; Yugang Wu
Journal:  J Gastrointest Surg       Date:  2018-10-17       Impact factor: 3.452

3.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

4.  Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study.

Authors:  Weihan Zhang; Xinzu Chen; Kai Liu; Kun Yang; Xiaolong Chen; Ying Zhao; Yongfan Zhao; Jiaping Chen; Longqi Chen; Jiankun Hu
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

5.  High-risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma.

Authors:  Masahiro Yura; Hiroya Takeuchi; Kazumasa Fukuda; Rieko Nakamura; Koichi Suda; Norihito Wada; Hirofumi Kawakubo; Yuko Kitagawa
Journal:  Ann Gastroenterol Surg       Date:  2018-10-13

6.  Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.

Authors:  Zi-Feng Yang; De-Qing Wu; Jun-Jiang Wang; Xing-Yu Feng; Jia-Bin Zheng; Wei-Xian Hu; Yong Li
Journal:  Ann Transl Med       Date:  2018-12

7.  Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.

Authors:  Chen-Bin Lv; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Comparisons of short-term and survival outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer patients.

Authors:  Xin-Zu Chen; Shao-Yong Wang; Yin-Su Wang; Zi-Han Jiang; Wei-Han Zhang; Kai Liu; Kun Yang; Xiao-Long Chen; Lin-Yong Zhao; Meng Qiu; Hong-Feng Gou; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2017-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.